RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • The benefits and risks of DPP4-inhibitors vs. sulfonylureas for patients with type 2 diabetes: accumulated evidence from randomised controlled trial.

The benefits and risks of DPP4-inhibitors vs. sulfonylureas for patients with type 2 diabetes: accumulated evidence from randomised controlled trial.

Add to Collection
2016 Feb RCTs Fist_Author_Year_PM

Full Author : ['Zhou, J-B', 'Bai, L', 'Wang, Y', 'Yang, J-K']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

AIM: To assess the efficacy and safety of dipeptidyl peptidase 4-inhibitors (DPP4-I) compared with sulphonylureas in adults with type 2 diabetes (T2D) mellitus. METHOD: Randomised controlled trials were collected from PubMed, EMBASE, Google Scholar and co.....

Keywords : ["type diabetes accumulate evidence", "randomised control trial", "vs sulfonylureas", "risk", "patient", "benefit"]